Prevention of prostatic diseases
Gudynskiĭ, I.V.; Boĭchenko, V.G.; Kozlov, N.P.
Voenno-MeditsinskiiZhurnal 1987(6): 56
1987
ISSN/ISBN: 0026-9050 PMID: 3660716 Document Number: 298569
Document emailed within 1 workday
Related Documents
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103García Delgado, F.; Bilbao Jaureguízar, J.I.; Ostiz Zubieta, S.; Aquerreta Beola, D.; Apesteguía Ciriza, L.; Gil López, J.A. 1984: Radiologic findings in prostatic diseases Revista de Medicina de la Universidad de Navarra 28(1): 29-34
Furuya, S. 1986: Mass screening of prostatic diseases Hokkaido Journal of Medical Science 61(4): 520
Chen, Z.-Q.; Mo, Z.-N. 2008: Curcumin in the treatment of prostatic diseases Zhonghua Nan Ke Xue 14(1): 67-70
Reichelt, H. 1974: Current treatment of prostatic diseases Zeitschrift für Allgemeinmedizin 50(15): 683-687
Olbrisch, R.R.; Sintermann, W.; Mauermayer, W. 1978: Andromastectomy for the prevention of gynecomastia in the treatment of prostatic cancer Fortschritte der Medizin 96(8): 372-373
Arora, H.L. 1979: Histochemistry of mucin in various human prostatic diseases Indian Journal of Pathology and Microbiology 22(4): 353-358
Pertschuk, L.P.; Zava, D.T.; Gaetjens, E.; Macchia, R.J.; Wise, G.J.; Kim, D.S.; Brigati, D.J. 1979: Histochemistry of steroid receptors in prostatic diseases Annals of Clinical and Laboratory Science 9(3): 225-229
Jichlinski, P. 2013: Urology. Trends in prostatic diseases in 2012 Revue Medicale Suisse 9(369): 147-149
Gadducci, P.; Cecchi, M.; Felipetto, R.; Viganò, L.; Minervini, R. 1993: Local hyperthermia in the treatment of benign prostatic diseases Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 65(2): 115-121
Radujkov, Z.; Berić, M.; Janca, K.; Ristic, D.; Sedlak, V.; Berić, K. 1981: Comparison of clinical and cytological findings in prostatic diseases Medicinski Pregled 34(1-2): 17-23
Rocchietta, S. 1977: Current phytotherapeutic agents in the treatment of prostatic diseases Minerva Medica 68(63): 4261-4264
Guo, X-Kun.; Bian, J.; Nie, Y.; Zhang, Z-Xiang.; Li, W-Li.; Zhang, Y.; Gao, W-Yang.; Feng, Y-Ju.; Cheng, S-Ping.; Xiang, Y-Jiu. 2003: Experimental study of vasoligation in the treatment and prevention of benign prostatic hyperplasia Zhonghua Nan Ke Xue 9(1): 20-23
Vagner, E.A.; Goriunov, V.G.; Davidov, M.I. 1998: The results of prostatic adenomectomy in patients with severe concomitant diseases Khirurgiia 8: 40-44
Kovács, A.; Harkányi, Z. 1989: Comparison of transabdominal and intrarectal ultrasonic studies in prostatic diseases Orvosi Hetilap 130(22): 1163-1166
Salihović, H. 2003: Primary prevention as the method of choice in the prevention and decrease of substance dependence diseases Medicinski Arhiv 57(5-6): 307-310
Shatokhin, M.N.; Teodorovich, O.V.; Konoplia, A.I.; Dolgareva, S.A.; Gavriliuk, V.P.; Krasnov, L.V.; Mavrin, M.I. 2012: Relations between red cell structure, function and immune homeostasis in prostatic diseases Urologiia 1: 42-46
Mosli, H.A.; Abdel-Meguid, T.A.; Al-Maghrabi, J.A.; Kamal, W.K.; Saadah, H.A.; Farsi, H.M. 2009: The clinicopathologic patterns of prostatic diseases and prostate cancer in Saudi patients Saudi Medical Journal 30(11): 1439-1443
Bouffioux, C. 1980: The importance of steroid and pituitary hormones in prostatic diseases. Discussion of a study Acta Urologica Belgica 48(4): 445-451
Mustafaev, E.M.; Martov, A.G.; Naumov, A.G.; Siniukhin, V.N.; Shakir, F.; Merinov, D.S.; Amelin, A.V.; Al'bitskaia, A.Iu. 2007: The role of ozone therapy in prevention of pyoinflammatory complications after transurethral resection of prostatic adenoma Urologiia 2007(1): 18-23 27